EPCAM and neoplasm: We then analyzed Nrf2 and EpCAM transcript levels by qRT-PCR and found that both transcripts were increased in cisplatin-resistant tumor cells (Fig. 3g), suggesting that resistance to cisplatin is due in part to an increased level of Nrf2 transcriptional activity and EpCAM overexpression.